33000sek
2,3 %
Date:2026-08-19Time:13:40:00Latest report:Q1-2026List:Large CapTicker:BIOA B
Market Cap:29 243 msekEnterprise Value:27 250 msekNet Sales:1 147 msekEarnings:213,2 msekEmployees:0ISIN:SE0010323311

Ratios

10-year key figure history for BioArctic turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for BioArctic with index and moving average MA50 and MA200.

Stockprice:325,60
MA50:313,87
MA200:314,17
Price/MA200:3,7 %
RSI (14):59,6
Price/MA50:3,8 %

Description

BioArctic is a biopharmaceutical company focused on developing new treatments that address the causes of neurodegenerative diseases. Examples of diseases include Alzheimer's and Parkinson's. A large part of the research is carried out in collaboration with researchers at universities and hospitals. BioArctic was founded in 2003 and is headquartered in Stockholm.

Biotechnology